PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma

Haoyu Li(Qingdao University), Jun Su(Shanghai Jiao Tong University), Suhua Chen(Henan University), Xin Chen(Hubei University of Technology), Chao Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianjun Sun(Shanghai Public Health Clinical Center), Qing Liu(Central South University), Kai Xiao(Central South University), Jun Yang(Peking University), Zhengxi He(Hunan Cancer Hospital), Qianquan Ma(Central South University)
OncoTargets and Therapy
January 1, 2021
10.2147/ott.s287931
Cited by 23

Related Papers

Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study
|Chinese Medical Journal|2020|1.4k
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
|Journal of Neuroinflammation|2019|746
Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors
|Proceedings of the National Academy of Sciences|2007|580
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
|BMJ|2022|494
Interactions within the yeast t-SNARE Sso1p that control SNARE complex assembly.
|Nature Structural Biology|2000|167